Literature DB >> 8043558

Menorrhagia--a pragmatic approach to the understanding of causes and the need for investigations.

I S Fraser1.   

Abstract

Menorrhagia is a symptom denoting excessively heavy menstrual bleeding. It is a complaint that is difficult to verify objectively in many cases, even with a detailed case history. Issues of perception and tolerance of symptoms are important in whether a patient presents to a doctor, and this varies considerably from one society to another. Research studies indicate that the upper limit of normal blood loss is between 60 and 80 ml/month. Above this level women tend to become progressively iron deficient. Hence, any development which may help the precision of this assessment is valuable, and several of these will be discussed. Causes of menorrhagia can be divided into three groups: (1) pelvic diseases, such as myomata and adenomyosis; (2) systemic disorders, such as coagulopathies and hypothyroidism; and (3) dysfunctional uterine bleeding--a diagnosis of exclusion. Investigations are mainly aimed at improving the precision of the underlying diagnosis, defining the severity of the condition and excluding anaemia. Hence, the most important investigations are a full blood count, a diagnostic hysteroscopy and endometrial sampling. In clinical practice, other specific investigations need only be carried out if there are unusual features in the history or examination, or if previous treatments have failed. In a research situation there have been numerous studies aimed at elucidation of the mechanisms of heavy bleeding and some of these will be reviewed.

Entities:  

Mesh:

Year:  1994        PMID: 8043558     DOI: 10.1111/j.1471-0528.1994.tb13688.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  5 in total

Review 1.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Referral for menstrual problems: cross sectional survey of symptoms, reasons for referral, and management.

Authors:  P Warner; H O Critchley; M A Lumsden; M Campbell-Brown; A Douglas; G Murray
Journal:  BMJ       Date:  2001-07-07

3.  Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims.

Authors:  Robert F Sidonio; Ayesha Zia; Dana Fallaize
Journal:  J Blood Med       Date:  2020-01-06

4.  Menstrual and obstetrical bleeding in women with inherited platelet receptor defects-A systematic review.

Authors:  Marieke C Punt; Pauline C E Schuitema; Kitty W M Bloemenkamp; Idske C L Kremer Hovinga; Karin P M van Galen
Journal:  Haemophilia       Date:  2020-01-31       Impact factor: 4.287

5.  Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm.

Authors:  A Kassam; J W Overstreet; C Snow-Harter; M J De Souza; E B Gold; B L Lasley
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.